Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Oragenics, Inc. (OGEN) had Return on Equity of 106.78% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.27M |
|
-- |
|
-- |
|
$1.71M |
|
$-1.71M |
|
$-0.56M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-1.71M |
|
$-1.14M |
|
0.73M |
|
0.73M |
|
$-3.10 |
|
$-3.10 |
|
| Balance Sheet Financials | |
$2.14M |
|
-- |
|
-- |
|
$2.14M |
|
$4.27M |
|
-- |
|
-- |
|
$4.27M |
|
$-2.13M |
|
$-2.13M |
|
$-2.13M |
|
0.82M |
|
| Cash Flow Statement Financials | |
$-3.43M |
|
-- |
|
$4.54M |
|
$0.86M |
|
$1.97M |
|
$1.11M |
|
$-0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
-- |
|
-1.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
106.78% |
106.78% |
|
-106.18% |
|
106.78% |
|
$-2.59 |
|
$-4.68 |
|
$-4.68 |
|